Sort
39,280 grants matching “leukemia”
Understanding Hemotopoietic Neoplasias using Humanized Mice
$1,063,218Richard A Flavell · Yale University · R01 · FY2010 · CA
Optimization of gene transfer and gene editing safety and efficacy focusing on the NHP model
$1,063,173Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Telomere Diseases
$1,062,495Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
University of Pennsylvania Patient-derived Xenograft Development and Trials Center
$1,062,215Martin Carroll · University Of Pennsylvania · U54 · FY2025 · CA
Epigenetic regulation of cellular plasticity and cancer cell fate
$1,062,000Yang Shi · Boston Children'S Hospital · R35 · FY2018 · CA
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$1,062,000David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$1,062,000David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
Towards targeting the lymphoma microenvironment
$1,062,000Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Towards targeting the lymphoma microenvironment
$1,062,000Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
TARGETING PCD FOR CANCER THERAPY
$1,061,323University Of Michigan At Ann Arbor · P01 · FY2001 · CA
Nervous System Development and Plasticity
$1,061,290Richard Douglas Fields · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Hydrogel Particle-Based microRNA Profiling for Discovery and Cancer Diagnostics
$1,060,790Daniel Pregibon · Firefly Bioworks, Inc. · R44 · FY2011 · CA
Mechanisms of Mammalian Epigenome Reprogramming
$1,060,437Todd Scott Macfarlan · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
$1,060,200Anthony G Letai · Dana-Farber Cancer Inst · R35 · FY2020 · CA
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
$1,060,200Anthony G Letai · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Retrovirus Assembly and Maturation
$1,059,418Alan Rein · Basic Sciences · Z01 · FY2007 · CA
Follow-Up Studies of a Genome-Wide Association Analysis in Pima Indians
$1,059,022Leslie J Baier · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
TET enzymes as guardians of genome stability
$1,058,400Anjana Rao · La Jolla Institute For Immunology · R35 · FY2022 · CA
Hematopoietic Stem Cell and Cord Blood Transplantation
$1,058,211Effie W Petersdorf · Fred Hutchinson Cancer Research Center · U01 · FY2010 · AI
Myelodysplasia
$1,057,808Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Development of humanized models using human induced pluripotent stem cells
$1,056,953John K. Critser · University Of Missouri-Columbia · RC2 · FY2009 · HL
Developing Efficient and Safe Gene Transfer to Primate Hematopoietic Stem Cells
$1,056,912Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Cancer Risk and Environmental Exposures to Nitrate, Pesticides, and Industrial C
$1,056,634Mary H Ward · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
MOLECULAR PATHOGENESIS OF CHROMOSOME 16 INVERSION INHUMAN LEUKEMIA
$1,056,349Paul Liu · National Human Genome Research Institute · ZIA · FY2010 · HG
Flow Cytometric Analysis of Benign and Malignant Tumors
$1,056,302Maryalice Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIC · FY2009 · CA